United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $24.13 billion. The enterprise value is $20.66 billion.
| Market Cap | 24.13B |
| Enterprise Value | 20.66B |
Important Dates
The last earnings date was Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 42.45 million shares outstanding. The number of shares has decreased by -1.40% in one year.
| Current Share Class | 42.45M |
| Shares Outstanding | 42.45M |
| Shares Change (YoY) | -1.40% |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 1.98% |
| Owned by Institutions (%) | 104.91% |
| Float | 38.91M |
Valuation Ratios
The trailing PE ratio is 21.00 and the forward PE ratio is 19.95. UTHR's PEG ratio is 2.05.
| PE Ratio | 21.00 |
| Forward PE | 19.95 |
| PS Ratio | 7.61 |
| Forward PS | 7.20 |
| PB Ratio | 4.06 |
| P/TBV Ratio | 4.17 |
| P/FCF Ratio | 23.73 |
| P/OCF Ratio | 15.43 |
| PEG Ratio | 2.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.34, with an EV/FCF ratio of 20.31.
| EV / Earnings | 16.05 |
| EV / Sales | 6.52 |
| EV / EBITDA | 13.34 |
| EV / EBIT | 14.15 |
| EV / FCF | 20.31 |
Financial Position
The company has a current ratio of 4.79
| Current Ratio | 4.79 |
| Quick Ratio | 4.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 89.03 |
Financial Efficiency
Return on equity (ROE) is 20.26% and return on invested capital (ROIC) is 29.36%.
| Return on Equity (ROE) | 20.26% |
| Return on Assets (ROA) | 12.62% |
| Return on Invested Capital (ROIC) | 29.36% |
| Return on Capital Employed (ROCE) | 23.88% |
| Weighted Average Cost of Capital (WACC) | 7.52% |
| Revenue Per Employee | $2.26M |
| Profits Per Employee | $919,571 |
| Employee Count | 1,400 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.47 |
Taxes
In the past 12 months, UTHR has paid $321.30 million in taxes.
| Income Tax | 321.30M |
| Effective Tax Rate | 19.97% |
Stock Price Statistics
The stock price has increased by +83.55% in the last 52 weeks. The beta is 0.60, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +83.55% |
| 50-Day Moving Average | 564.33 |
| 200-Day Moving Average | 476.03 |
| Relative Strength Index (RSI) | 49.76 |
| Average Volume (20 Days) | 408,134 |
Short Selling Information
The latest short interest is 2.45 million, so 5.77% of the outstanding shares have been sold short.
| Short Interest | 2.45M |
| Short Previous Month | 2.70M |
| Short % of Shares Out | 5.77% |
| Short % of Float | 6.29% |
| Short Ratio (days to cover) | 4.31 |
Income Statement
In the last 12 months, UTHR had revenue of $3.17 billion and earned $1.29 billion in profits. Earnings per share was $27.07.
| Revenue | 3.17B |
| Gross Profit | 2.74B |
| Operating Income | 1.46B |
| Pretax Income | 1.61B |
| Net Income | 1.29B |
| EBITDA | 1.55B |
| EBIT | 1.46B |
| Earnings Per Share (EPS) | $27.07 |
Balance Sheet
The company has $2.15 billion in cash and n/a in debt, with a net cash position of $3.47 billion or $81.78 per share.
| Cash & Cash Equivalents | 2.15B |
| Total Debt | n/a |
| Net Cash | 3.47B |
| Net Cash Per Share | $81.78 |
| Equity (Book Value) | 5.90B |
| Book Value Per Share | 139.98 |
| Working Capital | 2.27B |
Cash Flow
In the last 12 months, operating cash flow was $1.56 billion and capital expenditures -$546.40 million, giving a free cash flow of $1.02 billion.
| Operating Cash Flow | 1.56B |
| Capital Expenditures | -546.40M |
| Depreciation & Amortization | 88.40M |
| Net Borrowing | -200.00M |
| Free Cash Flow | 1.02B |
| FCF Per Share | $23.96 |
Margins
Gross margin is 86.58%, with operating and profit margins of 46.06% and 40.61%.
| Gross Margin | 86.58% |
| Operating Margin | 46.06% |
| Pretax Margin | 50.75% |
| Profit Margin | 40.61% |
| EBITDA Margin | 48.85% |
| EBIT Margin | 46.06% |
| FCF Margin | 32.08% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.40% |
| Shareholder Yield | 1.40% |
| Earnings Yield | 5.34% |
| FCF Yield | 4.21% |
Analyst Forecast
The average price target for UTHR is $663.58, which is 16.74% higher than the current price. The consensus rating is "Buy".
| Price Target | $663.58 |
| Price Target Difference | 16.74% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 9.63% |
| EPS Growth Forecast (5Y) | 9.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 16.45 and a Piotroski F-Score of 5.
| Altman Z-Score | 16.45 |
| Piotroski F-Score | 5 |